221 related articles for article (PubMed ID: 25899918)
21. NUPR1 and its potential role in cancer and pathological conditions (Review).
Martin TA; Li AX; Sanders AJ; Ye L; Frewer K; Hargest R; Jiang WG
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760183
[TBL] [Abstract][Full Text] [Related]
22. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
[TBL] [Abstract][Full Text] [Related]
23. Induction of NUPR1 and AP‑1 contributes to the carcinogenic potential of nickel.
Murphy A; Roy N; Sun H; Jin C; Costa M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649793
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.
Li J; Ren S; Liu Y; Lian Z; Dong B; Yao Y; Xu Y
J Neurooncol; 2017 Mar; 132(1):15-26. PubMed ID: 28000106
[TBL] [Abstract][Full Text] [Related]
26. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.
van der Watt PJ; Leaner VD
Biochim Biophys Acta; 2011 Jul; 1809(7):316-26. PubMed ID: 21683812
[TBL] [Abstract][Full Text] [Related]
27. Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer.
Murphy A; Costa M
Cancer Lett; 2020 Dec; 494():132-141. PubMed ID: 32835767
[TBL] [Abstract][Full Text] [Related]
28. Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1).
Santofimia-Castaño P; Rizzuti B; Abián O; Velázquez-Campoy A; Iovanna JL; Neira JL
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1283-1295. PubMed ID: 29530795
[TBL] [Abstract][Full Text] [Related]
29. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
[TBL] [Abstract][Full Text] [Related]
31. Identification of a functional p53 responsive element within the promoter of XAF1 gene in gastrointestinal cancer cells.
Zhang W; Guo Z; Jiang B; Niu L; Xia G; Wang X; Cheng T; Zhang Y; Wang J
Int J Oncol; 2010 Apr; 36(4):1031-7. PubMed ID: 20198350
[TBL] [Abstract][Full Text] [Related]
32. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
Liu YC; Chang PY; Chao CC
Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
[TBL] [Abstract][Full Text] [Related]
33. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.
Pedrola N; Devis L; Llauradó M; Campoy I; Martinez-Garcia E; Garcia M; Muinelo-Romay L; Alonso-Alconada L; Abal M; Alameda F; Mancebo G; Carreras R; Castellví J; Cabrera S; Gil-Moreno A; Matias-Guiu X; Iovanna JL; Colas E; Reventós J; Ruiz A
Clin Exp Metastasis; 2015 Jun; 32(5):467-78. PubMed ID: 25924802
[TBL] [Abstract][Full Text] [Related]
34. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
35. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
36. [Nuclear protein 1 knockdown inhibits proliferation and migration of HepG2 cells].
Huang H; Zhang Y; Wang X; Zhou X; Li S; Wang M; Ren J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):782-6. PubMed ID: 26062422
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27.
Li J; Lian ZG; Xu YH; Liu RY; Wei ZQ; Li T; Lv HT; Zhao YS; Liu YJ; Dong B; Fu X
Neoplasma; 2020 Jul; 67(4):843-850. PubMed ID: 32266819
[TBL] [Abstract][Full Text] [Related]
38. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
[TBL] [Abstract][Full Text] [Related]
39. Dendrimers as Competitors of Protein-Protein Interactions of the Intrinsically Disordered Nuclear Chromatin Protein NUPR1.
Neira JL; Correa J; Rizzuti B; Santofimia-Castaño P; Abian O; Velázquez-Campoy A; Fernandez-Megia E; Iovanna JL
Biomacromolecules; 2019 Jul; 20(7):2567-2576. PubMed ID: 31181156
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.
Engeland K
Cell Death Differ; 2018 Jan; 25(1):114-132. PubMed ID: 29125603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
